Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0150
-0.0050 (-25.00%)
At close: Mar 20, 2026
Appili Therapeutics Market Cap
Appili Therapeutics has a market cap or net worth of CAD 1.99 million as of March 20, 2026. Its market cap has decreased by -59.07% in one year.
Market Cap
1.99M
Enterprise Value
14.23M
Revenue
206.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since June 25, 2019, Appili Therapeutics's market cap has decreased from 26.83M to 1.99M, a decrease of -92.60%. That is a compound annual growth rate of -32.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.99M | -38.13% |
| Dec 29, 2025 | 3.21M | -24.39% |
| Dec 30, 2024 | 4.24M | - |
| Dec 29, 2023 | 4.24M | -22.22% |
| Dec 30, 2022 | 5.46M | -33.42% |
| Dec 31, 2021 | 8.20M | -89.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XORTX Therapeutics | 4.46M |
| ASEP Medical Holdings | 3.56M |
| BioVaxys Technology | 3.53M |
| COSCIENS Biopharma | 3.50M |
| Cytophage Technologies | 3.38M |
| Gemina Laboratories | 3.06M |
| Algernon Health | 2.17M |
| Rakovina Therapeutics | 2.11M |